Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (501-510 of 941) with videos related to

Pageof 95
Sort By:
Cancer|July 13, 2012
Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to boneJoel B Nelson, Karim Fizazi, Kurt Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Expression and nuclear localization of ErbB3 in prostate cancerIsmaël Hervé Koumakpayi, Jean-Simon Diallo, Cécile Le Page, et al.
The Prostate|August 24, 2006
The effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cancer--results from a 4-month pre-radical prostatectomy studyM Gleave, J Qian, C Andreou, et al.
Molecular Cancer Therapeutics|March 16, 2013
A novel antiandrogen, Compound 30, suppresses castration-resistant and MDV3100-resistant prostate cancer growth in vitro and in vivoHidetoshi Kuruma, Hiroaki Matsumoto, Masaki Shiota, et al.
International Journal of Cancer|April 9, 2013
TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signalingNaokazu Ibuki, Mazyar Ghaffari, Mitali Pandey, et al.
Molecular Therapy. Nucleic Acids|November 25, 2019
Characterization of a Prostate- and Prostate Cancer-Specific Circular RNA Encoded by the Androgen Receptor GeneJindan Luo, Yinan Li, Wei Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancerK N Chi, M E Gleave, R Klasa, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 27, 2012
Salvage prostatectomy post-definitive radiation therapy: The Vancouver experienceNiall M Corcoran, Guilherme Godoy, Rodney C Studd, et al.
International Journal of Cancer|July 23, 2011
Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progressionLatif A Wafa, Helen Cheng, Nathan Plaa, et al.
Plant Direct|June 28, 2019
Ectopic expression of the <i>PISTILLATA</i> homologous <i>MdPI</i> inhibits fruit tissue growth and changes fruit shape in appleJia-Long Yao, Juan Xu, Sumathi Tomes, et al.
Pageof 95

Showing results (501-510 of 941) with videos related to

Sort By:
Pageof 95
Cancer|July 13, 2012
Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to boneJoel B Nelson, Karim Fizazi, Kurt Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Expression and nuclear localization of ErbB3 in prostate cancerIsmaël Hervé Koumakpayi, Jean-Simon Diallo, Cécile Le Page, et al.
The Prostate|August 24, 2006
The effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cancer--results from a 4-month pre-radical prostatectomy studyM Gleave, J Qian, C Andreou, et al.
Molecular Cancer Therapeutics|March 16, 2013
A novel antiandrogen, Compound 30, suppresses castration-resistant and MDV3100-resistant prostate cancer growth in vitro and in vivoHidetoshi Kuruma, Hiroaki Matsumoto, Masaki Shiota, et al.
International Journal of Cancer|April 9, 2013
TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signalingNaokazu Ibuki, Mazyar Ghaffari, Mitali Pandey, et al.
Molecular Therapy. Nucleic Acids|November 25, 2019
Characterization of a Prostate- and Prostate Cancer-Specific Circular RNA Encoded by the Androgen Receptor GeneJindan Luo, Yinan Li, Wei Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancerK N Chi, M E Gleave, R Klasa, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 27, 2012
Salvage prostatectomy post-definitive radiation therapy: The Vancouver experienceNiall M Corcoran, Guilherme Godoy, Rodney C Studd, et al.
International Journal of Cancer|July 23, 2011
Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progressionLatif A Wafa, Helen Cheng, Nathan Plaa, et al.
Plant Direct|June 28, 2019
Ectopic expression of the <i>PISTILLATA</i> homologous <i>MdPI</i> inhibits fruit tissue growth and changes fruit shape in appleJia-Long Yao, Juan Xu, Sumathi Tomes, et al.
Pageof 95